% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I36258959&atag=randomized
% 41 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{turner2015-26362286,
  author  = {Turner, R. S. and Thomas, R. G. and Craft, S. and van Dyck, C. H. and Mintzer, J. and Reynolds, B. A. and Brewer, J. B. and Rissman, R. A. and others},
  title   = {{A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease}},
  journal = {Neurology},
  year    = {2015},
  doi     = {10.1212/wnl.0000000000002035},
  pmid    = {26362286},
  url     = {https://doi.org/10.1212/wnl.0000000000002035}
}

@article{cummings2025-39780249,
  author  = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others},
  title   = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01666-7},
  pmid    = {39780249},
  url     = {https://doi.org/10.1186/s13195-024-01666-7}
}

@article{quinn2010-21045096,
  author  = {Quinn, J. F. and Raman, R. and Thomas, R. G. and Yurko-Mauro, K. and Nelson, E. B. and Van Dyck, C. and Galvin, J. E. and Emond, J. and others},
  title   = {{Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial}},
  journal = {JAMA},
  year    = {2010},
  doi     = {10.1001/jama.2010.1510},
  pmid    = {21045096},
  url     = {https://doi.org/10.1001/jama.2010.1510}
}

@article{aisen2008-18854539,
  author  = {Aisen, P. S. and Schneider, L. S. and Sano, M. and Diaz-Arrastia, R. and van Dyck, C. H. and Weiner, M. F. and Bottiglieri, T. and Jin, S. and others},
  title   = {{High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2008},
  doi     = {10.1001/jama.300.15.1774},
  pmid    = {18854539},
  url     = {https://doi.org/10.1001/jama.300.15.1774}
}

@article{craft2020-32568367,
  author  = {Craft, S. and Raman, R. and Chow, T. W. and Rafii, M. S. and Sun, C. K. and Rissman, R. A. and Donohue, M. C. and Brewer, J. B. and others},
  title   = {{Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2020},
  doi     = {10.1001/jamaneurol.2020.1840},
  pmid    = {32568367},
  url     = {https://doi.org/10.1001/jamaneurol.2020.1840}
}

@article{salloway2025-39556389,
  author  = {Salloway, S. and Wojtowicz, J. and Voyle, N. and Lane, C. A. and Klein, G. and Lyons, M. and Rossomanno, S. and Mazzo, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2024.3937},
  pmid    = {39556389},
  url     = {https://doi.org/10.1001/jamaneurol.2024.3937}
}

@article{sano2011-21795660,
  author  = {Sano, M. and Bell, K. L. and Galasko, D. and Galvin, J. E. and Thomas, R. G. and van Dyck, C. H. and Aisen, P. S.},
  title   = {{A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e318228bf11},
  pmid    = {21795660},
  url     = {https://doi.org/10.1212/wnl.0b013e318228bf11}
}

@article{wagemann2024-38683602,
  author  = {Wagemann, O. and Liu, H. and Wang, G. and Shi, X. and Bittner, T. and Scelsi, M. A. and Farlow, M. R. and Clifford, D. B. and others},
  title   = {{Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2024},
  doi     = {10.1001/jamaneurol.2024.0991},
  pmid    = {38683602},
  url     = {https://doi.org/10.1001/jamaneurol.2024.0991}
}

@article{aisen2011-22291741,
  author  = {Aisen, P. S. and Gauthier, S. and Ferris, S. H. and Saumier, D. and Haine, D. and Garceau, D. and Duong, A. and Suhy, J. and others},
  title   = {{Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)}},
  journal = {Archives of medical science : AMS},
  year    = {2011},
  doi     = {10.5114/aoms.2011.20612},
  pmid    = {22291741},
  url     = {https://doi.org/10.5114/aoms.2011.20612}
}

@article{fleisher2011-21917762,
  author  = {Fleisher, A. S. and Truran, D. and Mai, J. T. and Langbaum, J. B. and Aisen, P. S. and Cummings, J. L. and Jack, C. R. and Weiner, M. W. and others},
  title   = {{Chronic divalproex sodium use and brain atrophy in Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e318230a16c},
  pmid    = {21917762},
  url     = {https://doi.org/10.1212/wnl.0b013e318230a16c}
}

@article{cummings2026-41865758,
  author  = {Cummings, Jeffrey L and Atri, Alireza and Sano, Mary and Zetterberg, Henrik and Scheltens, Philip and Knop, Filip K and Johannsen, Peter and Wichmann, Christian Ahmad and others},
  title   = {{Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials}},
  journal = {The Lancet},
  year    = {2026},
  doi     = {10.1016/s0140-6736(26)00459-9},
  pmid    = {41865758},
  url     = {https://doi.org/10.1016/s0140-6736(26)00459-9}
}

@article{curtis2015-25622185,
  author  = {Curtis, C. and Gamez, J. E. and Singh, U. and Sadowsky, C. H. and Villena, T. and Sabbagh, M. N. and Beach, T. G. and Duara, R. and others},
  title   = {{Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density}},
  journal = {JAMA neurology},
  year    = {2015},
  doi     = {10.1001/jamaneurol.2014.4144},
  pmid    = {25622185},
  url     = {https://doi.org/10.1001/jamaneurol.2014.4144}
}

@article{fleisher2008-18695053,
  author  = {Fleisher, A. S. and Raman, R. and Siemers, E. R. and Becerra, L. and Clark, C. M. and Dean, R. A. and Farlow, M. R. and Galvin, J. E. and others},
  title   = {{Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2008},
  doi     = {10.1001/archneur.65.8.1031},
  pmid    = {18695053},
  url     = {https://doi.org/10.1001/archneur.65.8.1031}
}

@article{galasko2014-24696507,
  author  = {Galasko, D. and Bell, J. and Mancuso, J. Y. and Kupiec, J. W. and Sabbagh, M. N. and van Dyck, C. and Thomas, R. G. and Aisen, P. S. and others},
  title   = {{Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease}},
  journal = {Neurology},
  year    = {2014},
  doi     = {10.1212/wnl.0000000000000364},
  pmid    = {24696507},
  url     = {https://doi.org/10.1212/wnl.0000000000000364}
}

@article{rafii2011-21502597,
  author  = {Rafii, M. S. and Walsh, S. and Little, J. T. and Behan, K. and Reynolds, B. and Ward, C. and Jin, S. and Thomas, R. and others},
  title   = {{A phase II trial of huperzine A in mild to moderate Alzheimer disease}},
  journal = {Neurology},
  year    = {2011},
  doi     = {10.1212/wnl.0b013e318216eb7b},
  pmid    = {21502597},
  url     = {https://doi.org/10.1212/wnl.0b013e318216eb7b}
}

@article{schneider2019-31492718,
  author  = {Schneider, L. S. and Geffen, Y. and Rabinowitz, J. and Thomas, R. G. and Schmidt, R. and Ropele, S. and Weinstock, M. and {Ladostigil Study Group}},
  title   = {{Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000008239},
  pmid    = {31492718},
  url     = {https://doi.org/10.1212/wnl.0000000000008239}
}

@article{marcum2023-36598787,
  author  = {Marcum, Z. A. and Gabriel, N. and Bress, A. P. and Hernandez, I.},
  title   = {{Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries}},
  journal = {JAMA network open},
  year    = {2023},
  doi     = {10.1001/jamanetworkopen.2022.49370},
  pmid    = {36598787},
  url     = {https://doi.org/10.1001/jamanetworkopen.2022.49370}
}

@article{petersen2005-15829527,
  author  = {Petersen, R. C. and Thomas, R. G. and Grundman, M. and Bennett, D. and Doody, R. and Ferris, S. and Galasko, D. and Jin, S. and others},
  title   = {{Vitamin E and donepezil for the treatment of mild cognitive impairment}},
  journal = {The New England journal of medicine},
  year    = {2005},
  doi     = {10.1056/nejmoa050151},
  pmid    = {15829527},
  url     = {https://doi.org/10.1056/nejmoa050151}
}

@article{thal1996-8960716,
  author  = {Thal, L. J. and Schwartz, G. and Sano, M. and Weiner, M. and Knopman, D. and Harrell, L. and Bodenheimer, S. and Rossor, M. and others},
  title   = {{A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group}},
  journal = {Neurology},
  year    = {1996},
  doi     = {10.1212/wnl.47.6.1389},
  pmid    = {8960716},
  url     = {https://doi.org/10.1212/wnl.47.6.1389}
}

@article{gauthier2009-19536424,
  author  = {Gauthier, S. and Aisen, P. S. and Ferris, S. H. and Saumier, D. and Duong, A. and Haine, D. and Garceau, D. and Suhy, J. and others},
  title   = {{Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study}},
  journal = {The journal of nutrition, health \& aging},
  year    = {2009},
  doi     = {10.1007/s12603-009-0106-x},
  pmid    = {19536424},
  url     = {https://doi.org/10.1007/s12603-009-0106-x}
}

@article{mulnard2000-10697060,
  author  = {Mulnard, R. A. and Cotman, C. W. and Kawas, C. and van Dyck, C. H. and Sano, M. and Doody, R. and Koss, E. and Pfeiffer, E. and others},
  title   = {{Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study}},
  journal = {JAMA},
  year    = {2000},
  doi     = {10.1001/jama.283.8.1007},
  pmid    = {10697060},
  url     = {https://doi.org/10.1001/jama.283.8.1007}
}

@article{sabbagh2011-21192237,
  author  = {Sabbagh, M. N. and Agro, A. and Bell, J. and Aisen, P. S. and Schweizer, E. and Galasko, D.},
  title   = {{PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2011},
  doi     = {10.1097/wad.0b013e318204b550},
  pmid    = {21192237},
  url     = {https://doi.org/10.1097/wad.0b013e318204b550}
}

@article{gehrman2009-19155748,
  author  = {Gehrman, P. R. and Connor, D. J. and Martin, J. L. and Shochat, T. and Corey-Bloom, J. and Ancoli-Israel, S.},
  title   = {{Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2009},
  doi     = {10.1097/jgp.0b013e318187de18},
  pmid    = {19155748},
  url     = {https://doi.org/10.1097/jgp.0b013e318187de18}
}

@article{ancoliisrael2008-18795985,
  author  = {Ancoli-Israel, S. and Palmer, B. W. and Cooke, JR. and Corey-Bloom, J. and Fiorentino, L. and Natarajan, L. and Liu, L. and Ayalon, L. and others},
  title   = {{Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2008},
  doi     = {10.1111/j.1532-5415.2008.01934.x},
  pmid    = {18795985},
  url     = {https://doi.org/10.1111/j.1532-5415.2008.01934.x}
}

@article{lu2009-19528519,
  author  = {Lu, P. H. and Edland, S. D. and Teng, E. and Tingus, K. and Petersen, R. C. and Cummings, J. L. and {Alzheimer's Disease Cooperative Study Group}},
  title   = {{Donepezil delays progression to AD in MCI subjects with depressive symptoms}},
  journal = {Neurology},
  year    = {2009},
  doi     = {10.1212/wnl.0b013e3181aa52d3},
  pmid    = {19528519},
  url     = {https://doi.org/10.1212/wnl.0b013e3181aa52d3}
}

@article{vandyck2019-31329216,
  author  = {van Dyck, C. H. and Nygaard, H. B. and Chen, K. and Donohue, M. C. and Raman, R. and Rissman, R. A. and Brewer, J. B. and Koeppe, R. A. and others},
  title   = {{Effect of AZD0530 on Cerebral Metabolic Decline in Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.2050},
  pmid    = {31329216},
  url     = {https://doi.org/10.1001/jamaneurol.2019.2050}
}

@article{jeste2008-17637610,
  author  = {Jeste, D. V. and Blazer, D. and Casey, D. and Meeks, T. and Salzman, C. and Schneider, L. and Tariot, P. and Yaffe, K.},
  title   = {{ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia}},
  journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
  year    = {2008},
  doi     = {10.1038/sj.npp.1301492},
  pmid    = {17637610},
  url     = {https://doi.org/10.1038/sj.npp.1301492}
}

@article{burstein2014-24423155,
  author  = {Burstein, A. H. and Grimes, I. and Galasko, D. R. and Aisen, P. S. and Sabbagh, M. and Mjalli, A. M.},
  title   = {{Effect of TTP488 in patients with mild to moderate Alzheimer's disease}},
  journal = {BMC neurology},
  year    = {2014},
  doi     = {10.1186/1471-2377-14-12},
  pmid    = {24423155},
  url     = {https://doi.org/10.1186/1471-2377-14-12}
}

@article{johnson2013-23375563,
  author  = {Johnson, K. A. and Sperling, R. A. and Gidicsin, C. M. and Carmasin, J. S. and Maye, J. E. and Coleman, R. E. and Reiman, E. M. and Sabbagh, M. N. and others},
  title   = {{Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2013},
  doi     = {10.1016/j.jalz.2012.10.007},
  pmid    = {23375563},
  url     = {https://doi.org/10.1016/j.jalz.2012.10.007}
}

@article{jack2008-17452062,
  author  = {Jack, C. R. and Petersen, R. C. and Grundman, M. and Jin, S. and Gamst, A. and Ward, C. P. and Sencakova, D. and Doody, R. S. and others},
  title   = {{Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI}},
  journal = {Neurobiology of aging},
  year    = {2008},
  doi     = {10.1016/j.neurobiolaging.2007.03.004},
  pmid    = {17452062},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2007.03.004}
}

@article{doody2014-24450890,
  author  = {Doody, Rachelle Smith and Thomas, Ronald G. and Farlow, Martin Rhys and Iwatsubo, Takeshi and Vellas, Bruno J. and Joffe, Steven and Kieburtz, Karl D. and Raman, Rema and Sun, Xiaoying and Aisen, Paul S. S. and Siemers, Eric and Liu‐Seifert, Hong and Mohs, Richard C.},
  title   = {{Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1312889},
  pmid    = {24450890},
  url     = {https://doi.org/10.1056/nejmoa1312889}
}

@article{aisen2003-12783912,
  author  = {Aisen, P. S. and Schafer, K. A. and Grundman, M. and Pfeiffer, E. and Sano, M. and Davis, K. L. and Farlow, M. R. and Jin, S. and others},
  title   = {{Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial}},
  journal = {JAMA},
  year    = {2003},
  doi     = {10.1001/jama.289.21.2819},
  pmid    = {12783912},
  url     = {https://doi.org/10.1001/jama.289.21.2819}
}

@article{sano1997-9110909,
  author  = {Sano, Mary and Ernesto, Christopher and Thomas, Ronald G. and Klauber, Melville R. and Schafer, Kimberly A and Grundman, Michael and Woodbury, Peter and Growdon, John H. and Cotman, Carl W. and Pfeiffer, Eric A. and Schneider, Lon S. and Thal, Leon J.},
  title   = {{A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study}},
  journal = {New England Journal of Medicine},
  year    = {1997},
  doi     = {10.1056/nejm199704243361704},
  pmid    = {9110909},
  url     = {https://doi.org/10.1056/nejm199704243361704}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{doody2013-23883379,
  author  = {Doody, Rachelle Smith and Raman, Rema and Farlow, Martin Rhys and Iwatsubo, Takeshi and Vellas, Bruno J. and Joffe, Steven and Kieburtz, Karl D. and He, Feng and Sun, Xiaoying and Thomas, Ronald G. and Aisen, Paul S. S. and Siemers, Eric and Sethuraman, Gopalan and Mohs, Richard C.},
  title   = {{A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease}},
  journal = {New England Journal of Medicine},
  year    = {2013},
  doi     = {10.1056/nejmoa1210951},
  pmid    = {23883379},
  url     = {https://doi.org/10.1056/nejmoa1210951}
}

@article{sano1996-8876776,
  author  = {Sano, M. and Ernesto, C. and Klauber, M. R. and Schafer, K. and Woodbury, P. and Thomas, R. and Grundman, M. and Growdon, J. and others},
  title   = {{Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study}},
  journal = {Alzheimer disease and associated disorders},
  year    = {1996},
  doi     = {10.1097/00002093-199601030-00004},
  pmid    = {8876776},
  url     = {https://doi.org/10.1097/00002093-199601030-00004}
}

@article{doraiswamy2014-24614494,
  author  = {Doraiswamy, P. M. and Sperling, R. A. and Johnson, K. and Reiman, E. M. and Wong, T. Z. and Sabbagh, M. N. and Sadowsky, C. H. and Fleisher, A. S. and others},
  title   = {{Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study}},
  journal = {Molecular psychiatry},
  year    = {2014},
  doi     = {10.1038/mp.2014.9},
  pmid    = {24614494},
  url     = {https://doi.org/10.1038/mp.2014.9}
}

@article{schneider2019-31282954,
  author  = {Schneider, L. S. and Thomas, R. G. and Hendrix, S. and Rissman, R. A. and Brewer, J. B. and Salmon, D. P. and Oltersdorf, T. and Okuda, T. and others},
  title   = {{Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.1868},
  pmid    = {31282954},
  url     = {https://doi.org/10.1001/jamaneurol.2019.1868}
}

@article{galvin2025-41416579,
  author  = {Galvin, James E. and Tolea, Magdalena I. and Scharre, Douglas W. and Hamby, Mary E. and Iaci, Jennifer F. and Grundman, Michael and Caggiano, Anthony O.},
  title   = {{Phase 2 study of zervimesine (CT1812) in participants with mild‐to‐moderate dementia with Lewy bodies (DLB)}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.71004},
  pmid    = {41416579},
  url     = {https://doi.org/10.1002/alz.71004}
}

@article{ayalon2006-16473983,
  author  = {Ayalon, L. and Ancoli-Israel, S. and Stepnowsky, C. and Marler, M. and Palmer, B. W. and Liu, L. and Loredo, J. S. and Corey-Bloom, J. and others},
  title   = {{Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea}},
  journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry},
  year    = {2006},
  doi     = {10.1097/01.jgp.0000192484.12684.cd},
  pmid    = {16473983},
  url     = {https://doi.org/10.1097/01.jgp.0000192484.12684.cd}
}